Outcome with calcium channel antagonists after myocardial infarction: a community-based study.

[1]  M. Alderman,et al.  Effect of long-acting and short-acting calcium antagonists on cardiovascular outcomes in hypertensive patients , 1997, The Lancet.

[2]  L Goldman,et al.  Adverse Outcomes of Underuse of β-Blockers in Elderly Survivors of Acute Myocardial Infarction , 1997 .

[3]  C M O'Connor,et al.  Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group. , 1996, The New England journal of medicine.

[4]  L. Ferrucci,et al.  Calcium-channel blockade and incidence of cancer in aged populations , 1996, The Lancet.

[5]  M. Woodward,et al.  Sex differences in myocardial infarction and coronary deaths in the Scottish MONICA population of Glasgow 1985 to 1991. Presentation, diagnosis, treatment, and 28-day case fatality of 3991 events in men and 1551 events in women. , 1996, Circulation.

[6]  J. Guralnik,et al.  Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old , 1996, The Lancet.

[7]  R. Moulds.  Editorial: Calcium antagonists: the current controversy , 1996 .

[8]  R. Kloner,et al.  Nifedipine in ischemic heart disease. , 1995, Circulation.

[9]  F. Messerli,et al.  Nifedipine and mortality. Grave defects in the dossier. , 1995, Circulation.

[10]  B. Psaty,et al.  Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. , 1995, Circulation.

[11]  T. Raghunathan,et al.  The risk of myocardial infarction associated with antihypertensive drug therapies. , 1995, JAMA.

[12]  J. Buring,et al.  Calcium channel blockers and myocardial infarction. A hypothesis formulated but not yet tested. , 1995, JAMA.

[13]  H. Tunstall-Pedoe,et al.  Myocardial Infarction and Coronary Deaths in the World Health Organization MONICA Project: Registration Procedures, Event Rates, and Case‐Fatality Rates in 38 Populations From 21 Countries in Four Continents , 1994, Circulation.

[14]  K. Anderson,et al.  New models for predicting cardiovascular events. , 1994, Journal of clinical epidemiology.

[15]  C. Furberg,et al.  Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials. , 1993, JAMA.

[16]  G. Lamas,et al.  Do the results of randomized clinical trials of cardiovascular drugs influence medical practice? The SAVE Investigators. , 1992, The New England journal of medicine.

[17]  D. Waters.  Proischemic complications of dihydropyridine calcium channel blockers. , 1991, Circulation.

[18]  C P Bradley,et al.  Decision making and prescribing patterns--a literature review. , 1991, Family practice.

[19]  C. Furberg,et al.  Update of effects of calcium antagonists in myocardial infarction or angina in light of the second Danish Verapamil Infarction Trial (DAVIT-II) and other recent studies. , 1991, The American journal of cardiology.

[20]  M. Eccles,et al.  Use of secondary prophylaxis against myocardial infarction in the north of England. , 1991, BMJ.

[21]  C. Furberg,et al.  Calcium channel blockers in acute myocardial infarction and unstable angina: an overview. , 1989, BMJ.

[22]  Eli Warnock,et al.  The effect of diltiazem on mortality and reinfarction after myocardial infarction. , 1989, The New England journal of medicine.

[23]  R. Califf,et al.  Trends in physician management of uncomplicated acute myocardial infarction, 1970 to 1987. , 1988, The American journal of cardiology.

[24]  F. Ebner,et al.  Early treatment of unstable angina in the coronary care unit: a randomised, double blind, placebo controlled comparison of recurrent ischaemia in patients treated with nifedipine or metoprolol or both. , 1988, British heart journal.

[25]  Joy,et al.  Trial of early nifedipine in acute myocardial infarction: the Trent study. , 1986, British medical journal.

[26]  A. J. Dunning,et al.  Early treatment of unstable angina in the coronary care unit: a randomised, double blind, placebo controlled comparison of recurrent ischaemia in patients treated with nifedipine or metoprolol or both. , 1988, British heart journal.

[27]  R. Kleiger,et al.  Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind, randomized, multicenter trial. , 1986, The New England journal of medicine.

[28]  E. W. Bough,et al.  Beneficial effects of high-dose diltiazem in patients with persistent effort angina on beta-blockers and nitrates: a randomized, double-blind, placebo-controlled cross-over study. , 1985, Circulation.

[29]  R. Peto,et al.  Beta blockade during and after myocardial infarction: an overview of the randomized trials. , 1985, Progress in cardiovascular diseases.

[30]  B Rosner,et al.  Nifedipine therapy for patients with threatened and acute myocardial infarction: a randomized, double-blind, placebo-controlled comparison. , 1984, Circulation.

[31]  J. Hill,et al.  Clinical outcome after treatment of rest angina with calcium blockers: comparative experience during the initial year of therapy with diltiazem, nifedipine, and verapamil. , 1983, American heart journal.

[32]  M. Bowles,et al.  Long-term antianginal action of verapamil assessed with quantitated serial treadmill stress testing. , 1981, The American journal of cardiology.

[33]  S. Kullander,et al.  HUMAN PLACENTAL LACTOGEN IN SCREENING FOR MULTIPLE PREGNANCIES , 1975, The Lancet.

[34]  R. Norris,et al.  A new coronary prognostic index. , 1970, Lancet.

[35]  Eter,et al.  EFFECT OF AMLODIPINE ON MORBIDITY AND MORTALITY IN SEVERE CHRONIC HEART FAILURE , 2000 .

[36]  V. Salomaa,et al.  Mild myocardial infarction--a classification problem in epidemiologic studies. WHO MONICA Project. , 1997, Journal of clinical epidemiology.

[37]  J. F. Hansen,et al.  Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II--DAVIT II) , 1990, The American journal of cardiology.

[38]  Nie Fe.  Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II--DAVIT II) , 1990 .

[39]  Secondary prevention reinfarction Israeli nifedipine trial (SPRINT). A randomized intervention trial of nifedipine in patients with acute myocardial infarction. The Israeli Sprint Study Group. , 1988, European heart journal.

[40]  A. DeMaria,et al.  Efficacy of diltiazem in angina on effort: a multicenter trial. , 1982, The American journal of cardiology.

[41]  K. Mcintyre,et al.  Safety and efficacy of diltiazem hydrochloride for the treatment of stable angina pectoris: report of a cooperative clinical trial. , 1982, The American journal of cardiology.